41 related articles for article (PubMed ID: 32097694)
21. The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.
Angulo JC; Manini C; López JI; Pueyo A; Colás B; Ropero S
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922974
[TBL] [Abstract][Full Text] [Related]
22. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
Du C; Lv C; Feng Y; Yu S
J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
[TBL] [Abstract][Full Text] [Related]
23. Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy.
Jose A; Shenoy GG; Sunil Rodrigues G; Kumar NAN; Munisamy M; Thomas L; Kolesar J; Rai G; Rao PPN; Rao M
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751840
[TBL] [Abstract][Full Text] [Related]
24. The Histone Lysine-specific Demethylase 1 Inhibitor, SP2509 Exerts Cytotoxic Effects against Renal Cancer Cells through Downregulation of Bcl-2 and Mcl-1.
Wu K; Woo SM; Kwon TK
J Cancer Prev; 2020 Jun; 25(2):79-86. PubMed ID: 32647649
[TBL] [Abstract][Full Text] [Related]
25. Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications.
Kumar A; Kumari N; Sharma U; Ram S; Singh SK; Kakkar N; Kaushal K; Prasad R
Sci Rep; 2019 Jun; 9(1):8189. PubMed ID: 31160694
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinical significance of COMPASS family of histone methyltransferases in clear cell renal cell carcinoma.
Kumar A; Kumari N; Rai A; Singh SK; Kakkar N; Prasad R
Gene; 2018 Oct; 674():31-36. PubMed ID: 29944950
[TBL] [Abstract][Full Text] [Related]
27. SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.
Ferreira MJ; Pires-Luís AS; Vieira-Coimbra M; Costa-Pinheiro P; Antunes L; Dias PC; Lobo F; Oliveira J; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
Epigenetics; 2017; 12(12):1057-1064. PubMed ID: 29099276
[TBL] [Abstract][Full Text] [Related]
28.
Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
[TBL] [Abstract][Full Text] [Related]
29. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
30. The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.
Malagraba G; Yarmohammadi M; Javed A; Barceló C; Rubio-Tomás T
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327654
[TBL] [Abstract][Full Text] [Related]
31. Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers.
Kumar A; Kumari N; Nallabelli N; Prasad R
Indian J Clin Biochem; 2019 Apr; 34(2):123-132. PubMed ID: 31092985
[TBL] [Abstract][Full Text] [Related]
32. Expression profile of H3K4 demethylases with their clinical and pathological correlation in patients with clear cell renal cell carcinoma.
Kumar A; Kumari N; Nallabelli N; Sharma U; Rai A; Singh SK; Kakkar N; Prasad R
Gene; 2020 May; 739():144498. PubMed ID: 32097694
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
